3 Papers
1 Citations
Ying Liu is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Kinase & IκB kinase. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Protective effects of organic acid component from Taraxacum mongolicum Hand.-Mazz. against LPS-induced inflammation: Regulating the TLR4/IKK/NF-κB signal pathway
Nan Yang,Zibo Dong,Gang Tian,Maomao Zhu,Chao Li,Weiquan Bu,Juan Chen,Xuefeng Hou,Ying Liu,Gang Wang,Xiao-Bin Jia,Liuqing Di,Liang Feng +12 more
TL;DR: TMHM-OAC can reduce LPS-induced inflammation in NHBE cells and this function could be linked to the regulation of the TLR4/IKK/NF-kB pathway.
35
Patent
Autophagy revulsive for diabetic vascular complication treatment and application in medicine
Feng Liang,Xiaobin Jia,Chunfei Wang,Wang Gang,Ying Liu,Tan Wei +5 more
- 22 Feb 2017
TL;DR: In this paper, a new application for alisol B autophagy revulsive for treating diabetic and vascular complication, and the application in medicine is disclosed. But the application is limited to the treatment of kidney tubular epithelial cells and vascular endothelial cells.
1
Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses.
Juan Chen,Xuefeng Hou,Gang Wang,Qing-Xiang Zhong,Ying Liu,Huihui Qiu,Nan Yang,Jun-Fei Gu,Chun-fei Wang,Li Zhang,Jie Song,Luqi Huang,Xiao-Bin Jia,Ming-Hua Zhang,Liang Feng +14 more
TL;DR: Findings indicated that MC-TG ameliorated ER stress-related inflammation in the pathogenesis of DN, wherein the protective mechanism might be associated with the inhibition of IRE1/NF-κB activation.